These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ascitic versus solid growth of Ehrlich ascites tumor influenced by immunological factors. Culo F; Allegretti N; Marusić M Oncology; 1978; 35(1):15-21. PubMed ID: 625393 [TBL] [Abstract][Full Text] [Related]
4. In vitro measurement of cytotoxic antibodies in mouse-immune sera against mouse ascites tumor cells. Eng CP; Tolbert WR; Harnaha JB; Concannon JP Can J Microbiol; 1974 Dec; 20(12):1681-8. PubMed ID: 4479949 [No Abstract] [Full Text] [Related]
5. A kinetic aspect of the antibody production against Ehrlich tumor cells in mice bearing Ehrlich solid tumor. Kaneko Y; Nitta K; Umezawa H Gan; 1975 Oct; 66(5):573-5. PubMed ID: 1220993 [TBL] [Abstract][Full Text] [Related]
6. [Stimulation of cell division by Ehrlich carcinoma cell surface antibodies]. Segarra M; Alfonso M; Subiza JL; Coll J Rev Esp Oncol; 1984; 31(2):205-13. PubMed ID: 6443683 [TBL] [Abstract][Full Text] [Related]
7. The induction of a fatal desmoplastic mesothelial reaction in rabbits with mouse Ehrlich ascites carcinomata. Sinai Y; Reesal MR J Pathol; 1974 Mar; 112(3):129-37. PubMed ID: 4209683 [No Abstract] [Full Text] [Related]
8. Suppression of cell-mediated immunity through immune spleen cells against Ehrlich ascites tumor. Okubo S Nagoya J Med Sci; 1971 Mar; 33(4):329-40. PubMed ID: 5554418 [No Abstract] [Full Text] [Related]
9. Antibody formation for malignant tumor. II. Antigenicity of Ehrlich ascites tumor lipoprotein. Yamamoto Y; Tadatomo Y; Okamura S Acta Med Okayama (1952); 1970 Oct; 24(5):527-36. PubMed ID: 4256471 [No Abstract] [Full Text] [Related]
10. Different behaviour of thymus in hosts bearing skin homografts or ehrlich ascites carcinoma. Simu G; Kiricuţă I; Crivii MS; Nestor D Arch Geschwulstforsch; 1976; 46(3):183-6. PubMed ID: 9920 [TBL] [Abstract][Full Text] [Related]
11. Mouse immune ascites in immunoelectrophoresis. Wager O; Räsänen JA Ann Med Exp Biol Fenn; 1967; 45(2):170-3. PubMed ID: 4963438 [No Abstract] [Full Text] [Related]
12. Antibody formation for malignant tumor. 3. Antigenicity of peptide of ribosomal digest in Ehrlich ascites tumor. Yamamoto Y; Jituiki D; Yabuki Y Acta Med Okayama (1952); 1970 Oct; 24(5):534-7. PubMed ID: 4256472 [No Abstract] [Full Text] [Related]
13. Demonstration of a reaction between immunocytes and tumor cells. Wrba H; Reider C Boll Ist Sieroter Milan; 1971; 50(4):329-33. PubMed ID: 5170764 [No Abstract] [Full Text] [Related]
14. Antigens of the surface of mouse ascites tumour cells. I. Studies with rabbit anti-mouse cell sera. Boyle W; Davies DA Immunology; 1966 Oct; 11(4):353-9. PubMed ID: 5924620 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of Ehrlich ascites carcinoma (EAC) with antiserum to modified EAC. Das AK; Roy DK Indian J Exp Biol; 1985 Nov; 23(11):641-3. PubMed ID: 3833682 [No Abstract] [Full Text] [Related]
17. [Histochemical studies on the effect of antibody and serum factors on ascites tumor cells and mast cells]. Keller R Bibl Haematol; 1967; 27():95-101. PubMed ID: 4233209 [No Abstract] [Full Text] [Related]
18. Immunization of mice against Ehrlich ascites tumour using a hamster-Ehrlich ascites tumour hybrid cell line. Watkins JF; Chen L Nature; 1969 Sep; 223(5210):1018-22. PubMed ID: 4309463 [No Abstract] [Full Text] [Related]
19. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM. Saha S; Mondal S Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of subcutaneous Ehrlich carcinoma by antihuman-somatotropic hormone serum of the horse as determined by the tumour-tetanus assay of the mouse. Lazarev AF; Schneeweiss U; Fabricius EM Arch Geschwulstforsch; 1976; 46(4):261-70. PubMed ID: 971044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]